What percent of VIVS is sold short?

57.5% of VivoSim Labs (VIVS) trading volume was short last week. Track days-to-cover and borrow rate against insider and hedge fund flow.

Is VIVS a short squeeze candidate?

Compare short volume, days-to-cover, and borrow rate to insider buying — when insiders accumulate against heavy short interest, the squeeze setup gets stronger.

How is short volume different from short interest?

Short volume is daily shorting activity reported by FINRA; short interest is the bi-monthly snapshot of outstanding short positions. We track both for VivoSim Labs (VIVS).

VIVS Short Volume Hit 57.5%

Also trades as: 0R02.L (LSE) · $vol 0M

$0.20

-0.01 (-5.35%)

Weekly Expected Move ±11.4%

$0 $0 $0 $0 $0

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $504478 mcap · 2M float · 141.03% daily turnover · Short 55% of daily vol

Short Volume Summary

2026-10-01

40.3%

Short Ratio

of total volume

43.6%

20-Day Avg

42.1%

50-Day Avg

▼ Falling

5-Day Trend

0.0M

Short Volume

0.1M

Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-01

Exchange	Short Volume	Total Volume	Short %
NASDAQ	41,786	102,718	40.7%
NYSE	841	3,056	27.5%

VIVS Short Interest

Short Volume Summary

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

Sign in to InsiderStreet